Studies indicated that PON1 can protect lipoproteins from oxidative modification, and observations indicated that individuals with low PON1 levels are at an increased risk of CVD
Early in treatment, the most prominent sensation is typically increased fullness after meals and reduced capacity to consume large portions
This process promotes fat metabolism, helping reduce harmful visceral fat while preserving lean body mass
The risk of B12 deficiency is particularly relevant for patients following plant-based diets, those with existing digestive disorders, or individuals with genetic variants affecting nutrient absorption pathways
Model-simulated concentration profiles demonstrated that at steady state, single deviations from the oral semaglutide recommended dosing conditions have a minimal impact on exposure
doi: 10.1155/2022/2944156